The U.S. Defense Logistics Agency (DLA) awarded a $1,957.43 firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S." This award is associated with Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has a performance period extending through December 17, 2024. This award is an unrestricted, non-set-aside contract.
Generated 3/17/25, 9:54 AM